Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions

Lung cancer is the most common cause of cancer-related death worldwide, and the prognosis for stage IV remains poor. The presence of genetic alterations in tumor cells, such as <i>EGFR</i> and <i>BRAF</i> gene mutations, as well as <i>ALK</i> and <i>ROS1<...

Full description

Bibliographic Details
Main Authors:	Katarzyna Stencel, Izabela Chmielewska, Janusz Milanowski, Rodryg Ramlau
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Cancers
Subjects:	lung cancer gene alterations targeted therapy <i>MET</i> amplification <i>MET</i> skipping mutation <i>NTRK</i> fusions
Online Access:	https://www.mdpi.com/2072-6694/13/8/1829

Similar Items

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
by: Patricia Mondelo-Macía, et al.
Published: (2020-02-01)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
by: Chiara Modica, et al.
Published: (2020-03-01)

<i>MET</i> Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer
by: Yu-Min Yeh, et al.
Published: (2021-08-01)

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma
by: Lisa Mayr, et al.
Published: (2020-12-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Molecular Targets for the Treatment of Metastatic Colorectal Cancer
by: Romain Cohen, et al.
Published: (2020-08-01)

Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer
by: Yaolin Song, et al.
Published: (2021-09-01)

Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
by: Yao J, et al.
Published: (2019-05-01)

<i>Helicobacter pylori</i> induces cancer cell motility independent of the c-Met receptor
by: Snider Jared, et al.
Published: (2009-01-01)

Novel <i>RB1</i> and <i>MET</i> Gene Mutations in a Case with Bilateral Retinoblastoma Followed by Multiple Metastatic Osteosarcoma
by: Attila Mokánszki, et al.
Published: (2021-12-01)

<i>Helicobacter pylori</i>-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients
by: Michael Doulberis, et al.
Published: (2021-06-01)

Avaliação morfoquantitativa e ultraestrutural da cartilagem do processo condilar da mandíbula e da sincondrose basioccipital de ratos Wistar subnutridos e suplementados com resveratrol
by: Joice Naiara Bertaglia Pereira
Published: (2015)

Avaliação morfoquantitativa e ultraestrutural da cartilagem do processo condilar da mandíbula e da sincondrose basioccipital de ratos Wistar subnutridos e suplementados com resveratrol
by: Pereira, Joice Naiara Bertaglia
Published: (2015)

Targeting <i>BRAF</i> Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer
by: Frank Aboubakar Nana, et al.
Published: (2021-09-01)

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients
by: Sébastien Perreault, et al.
Published: (2021-01-01)

Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer
by: Cristina Aguado, et al.
Published: (2021-02-01)

<i>CHI3L1</i>, <i>NTRK2</i>, <i>1p/19q</i> and <i>IDH</i> Status Predicts Prognosis in Glioma
by: Elise Deluche, et al.
Published: (2019-04-01)

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
by: Beung-Chul Ahn, et al.
Published: (2021-06-01)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2021-03-01)

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
by: Hiroaki Kanemura, et al.
Published: (2021-02-01)

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis
by: Antoine Italiano, et al.
Published: (2020-11-01)

Detection of Target-Site Herbicide Resistance in the Common Ragweed: Nucleotide Polymorphism Genotyping by Targeted Amplicon Sequencing
by: Barbara Kutasy, et al.
Published: (2021-03-01)

The Finnish New Variant of <em>Chlamydia trachomatis</em> with a Single Nucleotide Polymorphism in the 23S rRNA Target Escapes Detection by the Aptima Combo 2 Test
by: Kati Hokynar, et al.
Published: (2019-07-01)

Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
by: Subhayan Sur, et al.
Published: (2021-03-01)

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study
by: Kalapanida D, et al.
Published: (2019-05-01)

<i>NTRK</i> Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
by: Vasiliki Siozopoulou, et al.
Published: (2021-03-01)

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and <i>BDNF</i>/<i>TrkB</i> Gene Polymorphisms in Croatian Adults with Asthma
by: Katherina B. Sreter, et al.
Published: (2020-10-01)

<i>COMT</i> Val158Met (rs4680) polymorphism and vital exhaustion in an open 45–64-year-old population (international epidemiological WHO MONICA and HAPIEE programs)
by: V. V. Gafarov, et al.
Published: (2019-12-01)

<i>Helicobacter pylori</i>-Mediated Immunity and Signaling Transduction in Gastric Cancer
by: Nozomi Ito, et al.
Published: (2020-11-01)

<i>Entamoeba histolytica</i> Trophozoites Interact with the c-Met Receptor at the Surface of Liver Origin Cells through the Gal/GalNAc Amoebic Lectin
by: Jesus Pérez-Hernández, et al.
Published: (2021-09-01)

New Insights into the Pathogenesis of Systemic Mastocytosis
by: Zhixiong Li
Published: (2021-05-01)

Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients
by: Enrico Berrino, et al.
Published: (2021-07-01)

iPSC-Derived Embryoid Bodies as Models of c-<i>Met</i>-Mutated Hereditary Papillary Renal Cell Carcinoma
by: Jin Wook Hwang, et al.
Published: (2019-09-01)

Molecular Alterations in Dog Pheochromocytomas and Paragangliomas
by: Esther Korpershoek, et al.
Published: (2019-04-01)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
by: Bylicki O, et al.
Published: (2020-06-01)

Molecular Markers and Targets in Melanoma
by: Cristina Teixido, et al.
Published: (2021-09-01)

The Regulatory Effects of a Formulation of <i>Cinnamomum osmophloeum</i> Kaneh and <i>Taiwanofungus camphoratus</i> on Metabolic Syndrome and the Gut Microbiome
by: Ya-Yun Wang, et al.
Published: (2020-03-01)

Мамандандырылған сөздердiң векторлары арқылы сөздердiң лексикалық тiркесулерiн анықтау
by: O. A. Baimuratov, et al.
Published: (2020-09-01)

Secretory Carcinoma of Salivary Gland with High-Grade Histology Arising in Hard Palate: A Case Report
by: Kiyofumi Takabatake, et al.
Published: (2020-03-01)

<i>NTRK</i> Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis
by: Barbora Pekova, et al.
Published: (2021-04-01)